{"disease":{"id":"burn-wounds","name":"burn wounds"},"drugs":{"marketed":[{"drug_id":"daptomycin","indication_name":"Secondary infection of trauma, and burn wounds caused by MRSA","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cubicin","generic_name":"Daptomycin","company_name":"Baxter","drug_phase":"marketed","molecular_target":"","drug_class":"lipopeptide antibacterial","quality_score":59,"revenue":null,"mechanism":"Daptomycin is an antibacterial drug with lipopeptide structure."},{"drug_id":"cubicin","indication_name":"Secondary infection of trauma, and burn wounds caused by MRSA","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cubicin","company_name":"Clinical Alliance for Research & Education - Infectious Diseases, LLC.","drug_phase":"marketed","molecular_target":"Outer membrane porin protein OmpD","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"dapt","indication_name":"Secondary infection of trauma, and burn wounds caused by MRSA","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"DAPT","company_name":"Baxter Hlthcare Corp","drug_phase":"marketed","molecular_target":"Outer membrane porin protein OmpD","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Dapt is a small molecule that works by interacting with specific biological targets, but the exact details of this interaction are unknown."}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07025408","title":"Phase II Clinical Trial of KJ101in the Treatment of Deep II Degree Burns","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":144,"lead_sponsor_name":"Shanghai Bao Pharmaceuticals Co., Ltd.","has_results":false},{"nct_id":"NCT07530003","title":"HUMSCs Combined With Col I to Third-Degree Burn Wound","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":108,"lead_sponsor_name":"The First Affiliated Hospital of Xinxiang Medical College","has_results":false},{"nct_id":"NCT00343824","title":"Bacterial Control in Partial Thickness Burns Using Silver-containing Wound Dressings","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT06992895","title":"The Effect of Hologram Application on Pain, Anxiety, and Fear Levels in Children During Burn Dressing","phase":"NA","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Ataturk University","has_results":false},{"nct_id":"NCT06170008","title":"Efficacy of a Transparent Silicone Membrane With Physical Microstructure for Second-degree Burn Wounds and Skin Graft Wounds","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT07337616","title":"Field Shield Wound Dressing Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"KeriCure Medical","has_results":false},{"nct_id":"NCT05877638","title":"SWC for Treatment of Superficial Partial-Thickness Burns","phase":"NA","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Synedgen, Inc.","has_results":false},{"nct_id":"NCT06760611","title":"Tissue Quality of Integra vs. BTM Treated Burns","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Integra LifeSciences Corporation","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}